MX9604953A - Proteina que une heparina, para el tratamiento de sepsis y procesos para su preparacion. - Google Patents

Proteina que une heparina, para el tratamiento de sepsis y procesos para su preparacion.

Info

Publication number
MX9604953A
MX9604953A MX9604953A MX9604953A MX9604953A MX 9604953 A MX9604953 A MX 9604953A MX 9604953 A MX9604953 A MX 9604953A MX 9604953 A MX9604953 A MX 9604953A MX 9604953 A MX9604953 A MX 9604953A
Authority
MX
Mexico
Prior art keywords
heparin
binding protein
hbp
treatment
protein
Prior art date
Application number
MX9604953A
Other languages
English (en)
Other versions
MXPA96004953A (es
Inventor
Hans Jakob Hem Flodgarrd
Poul Baad Rasmussen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority claimed from PCT/DK1995/000121 external-priority patent/WO1995028949A1/en
Publication of MXPA96004953A publication Critical patent/MXPA96004953A/es
Publication of MX9604953A publication Critical patent/MX9604953A/es

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Se proporciona una composicion farmacéutica para la prevencion o tratamiento de enfermedades o condiciones asociadas con la induccion de la cascada de citocina por lipopolisacárido (LPS), la composicion comprende una proteína que une heparina (HBP) la cual, en forma glicosilada, tiene un peso molecular aparente de 28 KD (determinado por SDS-PAGE bajo condiciones reductoras), la proteína ha sido producida en los gránulos azurofilos de leucocitos polimorfonucleares, junto con un portador o diluyente farmacéuticamente aceptable. La proteína que une heparina se produce en células huésped que contienen ADN que codifica para HBP extendida en su parte N terminal o que codifica para HBP precedida por, y fusionada a una secuencia de ADN que codifica para otra proteína. También se describe un proceso en el que el medio de cultivo contiene un polisacárido sulfatado.
MX9604953A 1994-12-21 1995-03-17 Proteina que une heparina, para el tratamiento de sepsis y procesos para su preparacion. MX9604953A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DK0464/94 1994-04-21
DK1452/94 1994-12-21
DK145294 1994-12-21
PCT/DK1995/000121 WO1995028949A1 (en) 1994-04-21 1995-03-17 Heparin-binding protein for the treatment of sepsis and processes for its preparation

Publications (2)

Publication Number Publication Date
MXPA96004953A MXPA96004953A (es) 1998-02-01
MX9604953A true MX9604953A (es) 1998-02-28

Family

ID=39165030

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9604953A MX9604953A (es) 1994-12-21 1995-03-17 Proteina que une heparina, para el tratamiento de sepsis y procesos para su preparacion.

Country Status (1)

Country Link
MX (1) MX9604953A (es)

Similar Documents

Publication Publication Date Title
MX9708438A (es) Proteina principal de la membrana externa de moraxella, de alto peso molecular.
EP1770164A3 (en) Streptococcus pneumoniae antigens and vaccines
IL173399A (en) Circular dna molecules, processes for their preparation, pharmaceutical compositions comprising them and use thereof in the manufacture of medical products for producing recombinant proteins in vivo
FR2646437B1 (fr) Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
CA2000786A1 (en) 3-piperidinyl-1,2-benzisoxazoles
HU9602895D0 (en) Heparin-binding protein for the treatment of sepsis and processes for its preparation
HUP0000317A3 (en) Process for the preparation of recombinant proteins in e.coli by high cell density fermentation
CA2171699A1 (en) Expression of porcine reproductive respiratory syndrome virus polypeptides in the same cell
EP1522579A3 (en) Hyaluronan synthase gene and uses thereof
EP0905240A1 (en) Amino-terminally truncated c-c chemokines as chemokine antagonists
DE69233143D1 (de) Anti-hiv-proteine gap31, dap30 und dap32, die sie kodierende dna und ihre therapeutische nutzung
ES2017122A6 (es) Procedimiento de preparacion de proteina de ligado de heparina.
AU7237391A (en) Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine
RU96122777A (ru) Связывающий гепарин белок для лечения сепсиса и способы его получения
CA2126182A1 (en) Humanized antibodies reactive with gpiib/iiia
EP0369816A3 (en) Monoclonal antibodies specific for human polymorphic epithelial mucin
WO2003027297A1 (fr) Procede de production de $g(a)2,3/$g(a)2,8-sialyltransferase et sucre complexe contenant de l'acide sialique
MX9604953A (es) Proteina que une heparina, para el tratamiento de sepsis y procesos para su preparacion.
FR2689876B1 (fr) Dispersions silico-acryliques, leur procédé d'obtention, leur application en stéréophotolithographie et procédé de préparation d'objets en résine.
AU6892391A (en) Toughened polyamide and compositions, process for their preparation and moulded articles made therefrom
JP2969461B2 (ja) ヒトγ−インターフェロンとその製造方法並びに用途
AU2459188A (en) Anticoagulative protein pp4-x, and its preparation and use
Takeda et al. The production of a cytotoxic factor by mouse peritoneal macrophages and macrophage hybridomas treated with various stimulating agents
Yasuda et al. Partial purification and characterization of feline gamma-like interferon
FR2555577B1 (fr) Nouveaux derives de peptides, leur procede de preparation et leur emploi comme reactif biologique

Legal Events

Date Code Title Description
FG Grant or registration
PD Change of proprietorship

Owner name: LEUKOTECH A/S

MM Annulment or lapse due to non-payment of fees